1. Home
  2. CNTB

as 10-29-2025 9:37am EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Founded: 2012 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 94.2M IPO Year: 2021
Target Price: $7.50 AVG Volume (30 days): 79.5K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.81 EPS Growth: N/A
52 Week Low/High: $1.23 - $2.20 Next Earning Date: 11-30-2025
Revenue: $1,965,000 Revenue Growth: -91.85%
Revenue Growth (this year): -99.94% Revenue Growth (next year): 453067.90%

Share on Social Networks: